§ Player · Defender

Luís Mata

Kairat

In the 2025-26 Champions League, Luís Mata has an NVP of 58.

They produce 0.80 times their position's average and cost 0.63 times as much.

Their strongest skill is Defender: B, percentile 71.

They have a rating in 9 matches that season and were player of the match in 0. Their best rating was 65, in Kairat 0–5 Real Madrid.

Seasons

SeasonCompetitionTeamMinGAProducesCostsNVP
2025-26 Champions League Kairat 78700 0.80× 0.63× 58

Skills

Percentile against players in the same position in the 2025-26 Champions League, as on the app card.

StrikerX16
CreatorC47
DribblerC52
DefenderB71
ControlX15

Latest matches

  1. 60 Anderlecht 3–0 Kairat27 Aug · Europa League · 57'
  2. 40 Kairat 0–1 Levski Sofia11 Aug · Champions League · 90'
  3. 49 Arsenal 3–2 Kairat28 Jan · Champions League · 70'
  4. 47 Kairat 1–4 Club Brugge20 Jan · Champions League · 90'
  5. 60 Kairat 0–1 Olympiacos F.C.9 Dec · Champions League · 90'
  6. 41 Inter 2–1 Kairat5 Nov · Champions League · 90'
  7. 47 Kairat 0–0 Pafos FC21 Oct · Champions League · 90'
  8. 65 Kairat 0–5 Real Madrid30 Sep · Champions League · 90'
  9. 47 Sporting CP 4–1 Kairat18 Sep · Champions League · 80'
  10. 56 Kairat 0–0 Celtic26 Aug · Champions League · 119'

Best matches

  1. 65 Kairat 0–5 Real Madrid30 Sep 2025 · Champions League
  2. 60 Kairat 0–1 Olympiacos F.C.9 Dec 2025 · Champions League
  3. 60 Anderlecht 3–0 Kairat27 Aug 2026 · Europa League
  4. 56 Kairat 0–0 Celtic26 Aug 2025 · Champions League
  5. 51 Slovan Bratislava 1–0 Kairat12 Aug 2025 · Champions League

How is the rating calculated?

The rating measures a single match: what the player produced against what they cost, compared with the average for their position in that league and season, and adjusted by position (a 70 for a forward is as hard to get as a 70 for a defender). A normal match is around 50, 70 is already very good and only one in a hundred goes above 80. It is not the NVP, which ranks the whole season.

See their card in La Lente All their metrics, recent form, comparisons and Same DNA.